In an update to the public last week, the FDA announced that all but one animal drug company have committed to seek withdrawal of approvals for any production uses of affected drug applications and change the remaining therapeutic uses of their products from over-the-counter to use by Veterinary Feed Directive or prescription. These changes stem from the implementation of FDA Guidance #213 that was announced in December of last year. The FDA is pleased with the strong responses received thus far and promises to continue to provide updates to the public. For the official announcement from the FDA, read here.
Industry Commitment For Antibiotic Resistance Strategy
Recent GVL Blog Posts
Visit GVL at the AAEP Annual Conference
GVL is attending the 2019 American Association of Equine Practitioners (AAEP) Annual Convention & Trade Show in Denver, CO, December 7-11, 2019.The AAEP Annual Convention & Trade Show is the world’s largest continuing education event dedicated to equine...
Happy Thanksgiving from GVL
From everyone at GVL, we hope your Thanksgiving holiday is spent with the people (and animals) that you love. The GVL office will be closed Thursday, November 28th and Friday, November 29th.
International Health Certificates (CVIs)
We have heard from many veterinarians that helping their clients with international travel is stressful, complicated and confusing. The GVL team continues to work to understand our customers' needs for simplified international health certificates and requirements. We...
